NSEAcquisition6 Oct 2026 · 6 Oct 2026, 07:53 pm
Acquisition
Krishna Institute of Medical Sciences Limited · KIMS
✦ AI SummaryM&A
Krishna Institute of Medical Sciences Limited has informed the Exchange about the acquisition of 51% equity stake in Sarvottam Health Care Private Limited (Kakinada) for up to Rs. 80.00 Cr.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krishna Institute of Medical Sciences Limited has informed the Exchange about Acquisition
Attachments (1)
📄pdf
Download →
KIMS_06102026195302_Disclosure_to_Stock_Exchanges-06102026-Sarvottam.pdf
View document text
06th October, 2026
To, To,
The Secretary, The Secretary,
Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE),
Phiroze Jheejheebhoy Towers, Exchange Plaza,
Dalal Street, 5th Floor Plot No.C/1, 'G' Block
Mumbai - 400 001. Bandra - Kurla Complex
Scrip Code - 543308 Mumbai - 400 051.
ISIN: INE967H01025 Symbol - KIMS
Dear Sir/ Madam
Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition of 51% Equity Stake
in Sarvottam Health Care Private Limited (Kakinada), an O & M entity by investing upto Rs.
80.00 Cr – Reg.
Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the
Board of Directors of Krishna Institute of Medical Sciences Limited (“the Company”) at its meeting
held on today, i.e. 06th October, 2026 has approved the proposal for acquisition upto 51% equity stake
of the total paid-up equity share capital of Sarvottam Health Care Private Limited (Kakinada), an
O & M entity upto by investing Rs. 80.00 Cr.
We enclose herewith the details required under Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 read with SEBI Circular No.
SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as an Annexure-1 to this
letter.
Kindly take the above intimation on your records. This intimation is also uploaded on the Company’s
website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the
SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under
Regulation 30.
Thanking You,
Yours truly
For Krishna Institute of Medical Sciences Limited
Nagajayanthi J.R
Company Secretary and Compliance Officer
ANNEXURE -1
a Name of the target entity, details in brief Name of the target entity: Sarvottam Health care
such as size, turnover, etc., Private Limited.
Details in brief:
Sarvottam Health Care Private Limited (the
‘Company’) commenced operations in 2010 with
an initial capacity of 50 beds under the brand name
“Trust Multi Speciality Hospital”, with a present
capacity of 183 beds focusing on providing quality
healthcare services to the Kakinada region.
Recognizing the growing demand for advanced
medical care in East Godavari district, the
management invested in constructing a new
state-of-the-art hospital campus.
In 2021, hospital inaugurated a state of art hospital
building comprising of a cellar + ground floor with
7 upper floors (G+7 structure), with a total built-up
area of approximately 9847.23 square mtrs on a
company owned land ad measuring 3001 .36 Sq
Yards and commissioned additional 183 beds. This
makes Trust Hospitals as one of the largest and
most comprehensive healthcare providers in
Kakinada.
(Rs. in Crore)
FY 2025-26
Turnover: 84.83
PAT: 70.55
Networth: 50.30
b Whether the acquisition would fall within Acquisition of equity shares does not fall within
related party transaction(s) and whether the definition of Related Party Transaction.
the promoter / promoter group / group
companies have any interest in the entity
being acquired? If yes, nature of Interest
and details thereof and whether the same is
done at "Arms length":
c Industry to which the entity being acquired Healthcare Industry
belongs:
d Objects and effects of acquisition (including KIMS being the O & M Partner of the target entity
but not limited to, disclosure of reasons for has decided to acquire upto 51% of the total equity
acquisition of target entity, if its business is stake as a strategic investment.
outside the main line of business of the
listed entity
e Brief details of any governmental or regulatory Not Applicable.
approvals required for the acquisition:
f Indicative time period for completion of the On or before 31.10.2026
acquisition
g Consideration - whether cash consideration Cash.
or share swap and details of the same:
h Cost of acquisition or the price at which the The shares will be acquired based on the valuation
shares are acquired; report issued by BDO Valuation Advisory LLP
dated 05th October, 2026, for an aggregate
consideration up to ₹80.00 Crore (Rupees Eighty
Crore only).
i Percentage of shareholding/control KIMS will acquire upto 21,72,713 equity shares of
acquired and/or number of shares Rs. 10 each representing 51.00% of the equity
acquired; share capital of Target Company, for an aggregate
consideration of up to ₹80.00 Crore (Rupees
Eighty Crore only).
j Brief background about the entity acquired Brief background about the entity acquired: As
in terms of products/line of business mentioned in serial no. (a)
acquired, date of incorporation, history of
last 3 years turnover, country in which the
acquired entity has presence, and any other Date of Incorporation: 19-04-2011
significant information (in brief):
History of last 3 years Total Turnover of the
Company:
Particulars Amount in Crores
FY26 84.83
FY25 81.38
FY24 74.36
Presence: Kakinada, Andhra Pradesh - India
Other Significant Information: please refer to
the aforementioned.